Goldiam International Secures Rs. 60 Crore Lab-Grown Diamond Jewellery Export Orders

Market snapshot: Goldiam International Limited has announced the receipt of new export purchase orders aggregating to ₹60 crore for manufacturing and exporting lab-grown diamond jewellery. These orders are from international clients based in the USA and do not include online spot sales. The execution of the contract is scheduled to be completed on or before December 31, 2026, boosting near-term order book momentum.

Data Snapshot

• New export purchase orders secured for manufacturing and exporting lab-grown diamond jewellery total ₹60 crore.
• Consolidated net profit of the company rose ≈119.59% YoY (derived: ₹73.98 crore vs ₹33.69 crore) during Q1 FY27.
• Consolidated sales for Q1 FY27 increased 41.92% YoY (derived: ₹326.03 crore vs ₹229.73 crore) under strong export demand.

What's Changed

• The company's quarterly consolidated revenue grew 41.92% YoY to ₹326.03 crore in Q1 FY27, up from ₹229.73 crore in the corresponding period of the previous fiscal.
• The consolidated net profit surged to ₹73.98 crore in Q1 FY27 compared to ₹33.69 crore in Q1 FY26.

Key Takeaways

• Strong US Export Demand: The contract is awarded by USA-based international clients, emphasizing the robust traction of lab-grown diamond jewellery in North American markets.
• Order Execution Timeline: The ₹60 crore order is slated to be completed by December 31, 2026, which provides visibility for revenue generation in the current fiscal.
• Sequential Win: This order follows close on the heels of another ₹50 crore export order received on August 18, 2026, which is due for execution by November 30, 2026.
• Product Mix Shift: Goldiam's ongoing focus on high-margin lab-grown diamond studded jewellery continues to drive order acquisition and operational growth.

SAHI Perspective

Goldiam International's sequential order wins highlight its established position as a preferred supplier of lab-grown diamond (LGD) jewellery to leading US retail players. The focus on LGD products is a key driver of operating margins, which historically reached 28.6% on a reported basis in Q1 FY27. Furthermore, the quick execution timeline (under 4 months) reduces inventory risks and accelerates cash conversion. By expanding its retail brand, ORIGEM, alongside stable B2B exports, the company is successfully leveraging an omnichannel growth model.

Market Implications

The receipt of high-value export orders is expected to sustain positive sentiment around the stock. This comes amid a broader upward trend in the Indian gems and jewellery export sector, particularly driven by global consumer transition to sustainable lab-grown diamonds. However, international tariff structures and gold price volatility remain key external factors influencing net margin trends.

Trading Signals

Market Bias: Bullish

The consecutive export order wins of ₹60 crore and ₹50 crore within a month, combined with a strong 119.59% YoY rise in Q1 FY27 consolidated PAT to ₹73.98 crore, underline excellent operational momentum.

Overweight: Gems and Jewellery Exporters, Lab-Grown Diamond Manufacturers

Trigger Factors:

• Fulfillment of the current ₹60 crore order by December 31, 2026
• Expansion of the domestic ORIGEM retail footprint beyond 26 stores
• Stabilization of gold and lab-grown diamond raw material prices

Time Horizon: Near-term (0-3 months)

Industry Context

The gems and jewellery export sector in India has been actively adapting to macroeconomic headwinds, such as the US tariff changes. Exporters are shifting focus towards value-added jewellery pieces rather than loose stones. Lab-grown diamonds represent a high-growth segment, with Goldiam reporting that LGD jewellery contributes an overwhelming portion of its export sales mix. The company operates from the Special Economic Zone in Mumbai, enabling it to leverage custom duty exemption benefits.

Key Risks to Watch

• Client Concentration: These export orders are heavily reliant on USA-based retail clients, exposing the company to regional consumer demand slowdowns.
• Forex Volatility: Since the orders are international export contracts, fluctuations in the USD/INR exchange rate can directly impact realized margins.
• Input Cost Volatility: Sharp movements in the cost of raw materials, particularly gold used for diamond-studded jewellery, could squeeze gross margins.

Recent Developments

On August 18, 2026, Goldiam secured ₹50 crore export orders for supplying lab-grown diamond studded gold jewellery, to be executed on or before November 30, 2026. On August 7, 2026, the company announced its Q1 FY27 consolidated earnings, reporting a net profit of ₹73.98 crore (up 119.59% YoY) and revenue of ₹326.03 crore. On August 3, 2026, the company announced the opening of its 26th retail store for lab-grown diamond jewellery under its brand name 'ORIGEM'. In July 2026, the company successfully completed its 1:3 bonus equity shares distribution, with the ex-bonus date being July 10, 2026.

Closing Insight

Goldiam's ability to repeatedly secure high-value international orders confirms the steady global demand for its specialized lab-grown diamond jewellery. Investors should track the execution timelines and the company's domestic retail ramp-up via ORIGEM stores as primary performance indicators.

High Performance Trading with SAHI.